Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and represent the first new class of pain medications in 20 years—and the first non ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...

"Dry January" is a social movement encouraging sobriety for the month. More people, especially younger adults, are choosing ...